ClinicalTrials HQ

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM

Recruiting · NCT05836259 · Registry updated 2026-03-19
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCMCongenital, Hereditary, and Neonatal Diseases and Abnormalities, aortic valve disorder, aortic valve stenosis, cardiomyopathy, cardiovascular disorder, familial hypertrophic cardiomyopathy, heart disorder, heart valve disorder, hereditary disease, hypertrophic cardiomyopathy, subvalvular aortic stenosisRecruitingPhase 1 / Phase 22026-03-19NCT05836259

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Tenaya Therapeutics4

10 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Brigham and Women's HospitalBostonUnited States511
Cleveland ClinicClevelandUnited States558
Emory UniversityAtlantaUnited States262
Hospital of the University of PennsylvaniaPhiladelphiaUnited States142
Houston Methodist HospitalHoustonUnited States260
Mayo ClinicRochesterUnited States664
Oregon Health & Science UniversityPortlandUnited States261
The Christ Hospital Physicians - The Ohio Heart and Vascular CenterCincinnatiUnited States1
UC San Diego Altman Clinical and Translational Research Institute - Center for Clinical ResearchLa JollaUnited States1
University of California San FranciscoSan FranciscoUnited States4